Key result
Direct vision minimally invasive double valve replacement shows 0% in-hospital mortality.
Why the study?
To evaluate the in-hospital and early outcomes of direct vision minimally invasive double valve surgery at a tertiary care cardiac center in a developing country.
Does direct vision minimal invasive double valve surgery (DVMI-DVR) provide safe and feasible in-hospital outcomes in patients with aortic and mitral valve disease?
Observational (n=19)
No
Does direct vision minimal invasive double valve surgery (DVMI-DVR) provide safe and feasible in-hospital outcomes in patients with aortic and mitral valve disease?
Minimally invasive double valve replacement via anterior thoracotomy is a safe and feasible alternative to median sternotomy, with zero in-hospital mortality and acceptable recovery times in a small cohort.
DVMI-DVR shows acceptable early outcomes in one center; leaves open need for randomized trials before broader adoption.
Introduction Minimally invasive double valve replacement (DVR) surgery through a small transverse anterior thoracotomy is an alternate technique to sternotomy for concomitant aortic and mitral valve (AVR, MVR) surgery. The aim of this study was to evaluate the in-hospital and early outcomes of direct vision minimal invasive double valve surgery (DVMI-DVR) at a tertiary care cardiac center of a developing country. Methods This study was conducted at the National Institute of Cardiovascular Diseases Karachi, Pakistan from January 2018 to September 2018. Nineteen consecutive patients undergoing DVMI-DVR for aortic and mitral disease without any prior cardiac surgery were included in this study. For all procedures, access was obtained through small transverse anterior thoracotomy incision with wedge resection (Chaudhry's Wedge) of sternum opposite to the third and fourth costosternal joints. Patients were observed during their hospital stay and the following variables were observed the length of hospital stay (LOHS), ventilator support, intensive care unit (ICU) stay, pain score, and mortality. The pain score was assessed using the visual analog scale (VAS). Results The male/female ratio was 11:8 with a mean age of 35 ± 12 years with mean EuroSCORE of 6.6 ± 3.5%. The mean total bypass time was 129.8 ± 23.83 min (range: 98-181 minutes). The mean mechanical ventilation time was 3.16 ± 1.12 hours (range: 2-6 hours). The mean intensive care unit (ICU) stay was 41.84 ± 8.36 hours. The mean post-operative LOHS was 5.63 ± 1.12 days (range: 4-8 days). We had zero frequency of wound infection and surgical mortality. The mean pain score was 4.32 (on a predefined pain scale of one to nine with a high value indicating severe pain). Conclusion Minimally invasive DVR surgery is a safe and reproducible technique with comparable outcomes such as postoperative pain score (4.32 ± 2.05), ventilation time (3.16 ± 1.12 hours), ICU stay (41.84 ± 8.36 hours), and hospital stay (5.63 ± 1.12 days). In terms of mortality, operative times, ICU stay, and hospital stay, the minimally invasive DVR is at least comparable to those achieved with median sternotomy. Further prospective randomized studies are needed to validate our findings.
No takes yet. Share an insight, caveat, or question.
Zia et al. (2019) conducted an observational in Aortic and mitral valve disease (n=19). Direct vision minimal invasive double valve surgery (DVMI-DVR) was evaluated on In-hospital mortality. Direct vision minimally invasive double valve replacement was safe and reproducible, resulting in zero in-hospital mortality and a mean hospital stay of 5.63 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: